Angiotensin Converting Enzyme 2 (ACE2) G8790A Gene Polymorphism as a Risk Factor for Essential Hypertension
DOI:
https://doi.org/10.35898/ghmj-82s1231Keywords:
ACE2 gene, G8790A Polymorphism, Essential hypertensionAbstract
Background: Globally, the number of people with hypertension has doubled, from 650 million to 1.3 billion. The World Health Organization reported that hypertension is responsible for more than 10 million deaths every year. Essential hypertension is a multifactorial condition with genetics as one of the factors. Genome-Wide Association Study has identified several genes associated with hypertension, one of which is the Angiotensin Converting Enzyme 2 (ACE2) gene. Essential hypertension may be predisposed to by the G8790A polymorphism of the ACE2 gene, which is hypothesized to interfere with the normal function of the Renin Angiotensin System (RAS).
Aims: The purpose of this study is to determine whether the ACE2 G8790A gene polymorphism in Cirebon, West Java, Indonesia, is associated with an increased risk of essential hypertension.
Methods: This is a case-control study conducted at the Talun Health Center, Cirebon Regency, April-August 2024, involving 30 essential hypertensive patients and 30 healthy controls. The study population comprised adults aged 30 to 72 years. Data was obtained through the examination of blood pressure, DNA extraction, PCR-RFLP with ALUI restriction enzyme, and then visualization of the results with Gel Electrophoresis. The Chi-Square Test technique and the Odds Ratio (OR) computation were used to analyze the data.
Results: The G allele was higher in the case group 33 (55%), while the A allele was higher in the control group 34 (56.7%). The statistical analysis showed that there was no significant link between the ACE2 G8790A gene variation and essential hypertension, with a p-value of 0.592 (p > 0.05) (OR = 0.750; CI = 0.262–2.151).
Conclusion: The ACE2 gene G8790A polymorphism and the rate of hypertension in Cirebon, West Java, were not significantly correlated. Further research is required on a larger scale to investigate the effects of gene combinations or interactions with other locus genes on essential hypertension.
Downloads
References
ACE2 Gene. (2023). Retrieved from https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACE2
Alwi, I. (2014). Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi VI. Interna Publishing.
Benjafield, A. V., Wang, W. Y. S., & Morris, B. J. (2004). No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. American Journal of Hypertension, 17(7), 624–628. https://doi.org/10.1016/j.amjhyper.2004.02.022
Burrell, L. M., Johnston, C. I., Tikellis, C., & Cooper, M. E. (2004). ACE2, a new regulator of the renin-angiotensin system. Trends in Endocrinology and Metabolism, 15(4), 166–169. https://doi.org/10.1016/j.tem.2004.03.001
Chappell, M. C., Marshall, A. C., Alzayadneh, E. M., Shaltout, H. A., & Diz, D. I. (2014). Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: Fetal programing, sex differences, and intracellular pathways. Frontiers in Endocrinology, 5(JAN), 1–13. https://doi.org/10.3389/fendo.2013.00201
Fan, X. H., Wang, Y. B., Wang, H., Sun, K., Zhang, W. L., Song, X. D., … Hui, R. T. (2009). Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients. Acta Pharmacologica Sinica, 30(9), 1237–1244. https://doi.org/10.1038/aps.2009.110
Imai, Y., Kuba, K., Ohto-Nakanishi, T., & Penninger, J. M. (2010). Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circulation Journal, 74(3), 405–410.https://doi.org/10.1253/circj.CJ-10-0045
Kemenkes. (2021). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Hipertensi Dewasa. Kementerian Kesehatan RI, 1–85.
Kemenkes RI. (2018). Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehatan RI (Vol. 53).
Kuswara, H. N., Nauphar, D., & Sari, A. I. P. (2024). Angiotensin-Converting Enzyme Insertion/Deletion (ACE I/D) gene polymorphism as a risk factor for essential hypertension. GHMJ (Global Health Management Journal), 7(4), 180–190. https://doi.org/10.35898/ghmj-741044
Li, Y. Y. (2012). Lack of association of ACE2 G8790A gene mutation with essential hypertension in the Chinese Population: A meta-analysis involving 5260 subjects. Frontiers in Physiology, 3 SEP(September), 1–7.https://doi.org/10.3389/fphys.2012.00364
Lu, N., Yang, Y., Wang, Y., Liu, Y., Fu, G., Chen, D., … Zheng, Y. (2012). ACE2 gene polymorphism and essential hypertension: An updated meta-analysis involving 11,051 subjects. Molecular Biology Reports, 39(6), 6581–6589. https://doi.org/10.1007/s11033-012-1487-1
Lupton, S. J., Chiu, C. L., & Lind, J. M. (2011). A hypertension gene: Are we there yet? Twin Research and Human Genetics, 14(4), 295–304. https://doi.org/10.1375/twin.14.4.295
Olin, B. R., & Pharm, D. (2018). Hypertension : The Silent Killer : Updated JNC-8 Guideline Recommendations.
P2PTM Kemenkes RI. (2024a). Faktor Risiko Hipertensi yang Dapat Diubah dan Tidak Dapat Diubah. Retrieved from https://p2ptm.kemkes.go.id/infographic/faktor-risiko-hipertensi-yang-dapat-diubah-dan-tidak-dapat-diubah
P2PTM Kemenkes RI. (2024b). Mengenal Penyakit Hipertensi.
Pan, Y. (2023). Angiotensin-converting enzyme 2 G8790A polymorphisms are associated with COVID-19 severity. Journal of Infection in Developing Countries, 17(6), 819–825. https://doi.org/10.3855/jidc.17762
Pratamawati, T. M., Sadji, A. a. E. B., Brajadenta, G. S., & Nauphar, D. (2024b). Association of rs9939609 FTO Gene Polymorphism as a Risk Factor of Obesity in Adults. GHMJ (Global Health Management Journal), 7(1), 27–32. https://doi.org/10.35898/ghmj-71967
Sherwood, L. (2013). Introduction to human physiology. Brooks/Cole, Cengage Learning.
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., … Schutte, A. E. (2020). 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
World Health Organization. (2023). Global Report on Hypertension.
Yan, Q., Xu, C., Li, Z., Zhou, P., Ye, R., Li, M., & Jiang, C. (2008). [Relationship of angiotensin-converting enzyme 2 gene polymorphisms and vulnerability to coronary heart disease in patients with type 2 diabetes mellitus]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 28(8), 1365–1368. https://pubmed.ncbi.nlm.nih.gov/18753062/
Yang, M., Zhao, J., Xing, L., & Shi, L. (2015). The association between angiotensinconverting enzyme 2 polymorphisms and essential hypertension risk: A metaanalysis involving 14,122 patients. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 16(4), 1240–1244. https://doi.org/10.1177/1470320314549221
Yang, Y. L., Mo, Y. P., He, Y. S., Yang, F., Xu, Y., Li, C. C., … Long, L. (2015). Correlation between renin-angiotensin system gene polymorphisms and essential hypertension in the Chinese Yi ethnic group. JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 16(4), 975–981. https://doi.org/10.1177/1470320315598697
Yi, L., Gu, Y. H., Wang, X. L., An, L. Z., Xie, X. D., Shao, W., … Zhang, D. L. (2006). Association of ACE, ACE2 and UTS2 polymorphisms wih essential hypertension in Han and Dongxiang populations from North-western China. Journal of International Medical Research, 34(3), 272–283. https://doi.org/10.1177/147323000603400306
Younas, H., Ijaz, T., & Choudhry, N. (2022). Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population. PLoS ONE, 17(2 February), 1–16. https://doi.org/10.1371/journal.pone.0264038
Zhang, X., Wang, Y., Zheng, Y., Yuan, J., Tong, J., Xu, J., … Li, X. (2022). Effect of ACE, ACE2 and CYP11B2 gene polymorphisms and noise on essential hypertension among steelworkers in China: a case–control study. BMC Medical Genomics, 15(1), 1–10. https://doi.org/10.1186/s12920-022-01177-0
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., … Zuñiga Cisneros, J. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Nazaul Husna, S.Ked, Donny Nauphar, B.Sc.(Biotech), M.Si.Med., dr. Tiar Masykuroh Pratamawati, M.M., M.Biomed
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
GHMJ (Global Health Management Journal) conforms fully to The Budapest Open Access Initiative (BOAI) and DOAJ Open Access Definition. Authors, readers, and reviewers are free to Share ” copy and redistribute the material in any medium or format, and Adapt ” remix, transform, and build upon the material. Author(s) retain unrestricted copyrights and publishing rights of their work. The licensor cannot revoke these freedoms as long as you follow the license terms. Learn the details at the License policy.
How to Cite
